Genome-wide association studies in Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Genome-wide association studies (GWAS) have gained considerable momentum over the last couple of years for the identification of novel complex disease genes. In the field of Alzheimer's disease (AD), there are currently eight published and two provisionally reported GWAS, highlighting over two dozen novel potential susceptibility loci beyond the well-established APOE association. On the basis of the data available at the time of this writing, the most compelling novel GWAS signal has been observed in GAB2 (GRB2-associated binding protein 2), followed by less consistently replicated signals in galanin-like peptide (GALP), piggyBac transposable element derived 1 (PGBD1), tyrosine kinase, non-receptor 1 (TNK1). Furthermore, consistent replication has been recently announced for CLU (clusterin, also known as apolipoprotein J). Finally, there are at least three replicated loci in hitherto uncharacterized genomic intervals on chromosomes 14q32.13, 14q31.2 and 6q24.1 likely implicating the existence of novel AD genes in these regions. In this review, we will discuss the characteristics and potential relevance to pathogenesis of the outcomes of all currently available GWAS in AD. A particular emphasis will be laid on findings with independent data in favor of the original association.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Genetic studies have identified numerous AD risk variants in immune‐ and microglial‐associated genes, highlighting the importance of microglia function in disease progression. 3 , 4 , 5 , 6 , 7”
From Alzheimer's disease–associated PLCG2 variants alter microglial state and function in human induced pluripotent stem cell–derived microglia‐like cells (2025) · cites this paper as [3]
In the citing paper
“In addition, we found the APOE and APP subnetwork within the vesicle mediated transport pathway which are among the most significant genetic risk factors for AD (Figure 5F).46,47,48”
From SCING: Inference of robust, interpretable gene regulatory networks from single cell and spatial transcriptomics (2023) · cites this paper as [46]
Citations
Cites
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268 · cited 1×
“However, with the exception of one genetic variant, the 14-allele of the apolipoprotein E gene (APOE) (6,7) none of these candidates has been proven to consistently influence disease risk or onset age in more than a handful of samples.”
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2344 · Cited by 2,891 · cited 1×
“For many genetically complex diseases, the GWAS approach has yielded an unexpectedly large number of genome-wide significant findings that were confirmed by independent follow-up studies (9,10).”
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857 · cited 3×
“In the quest to uncover the late-onset AD genes, a vast body of data has been accrued over the past 30 years in well over 1200 studies assessing more than 500 different genes as potential risk factors, mostly using a candidate gene-based approach (5).”
InfluentialSelf-citationTwenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective
Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849
Self-citationThirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses
Bertram, L., & Tanzi, R. E. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2494 · Cited by 747
Self-citationCoon, K. D., Myers, A. J., Craig, D. W., Webster, J. A., Pearson, J. V., Lince, D. H., Zismann, V. L., Beach, T. G., Leung, D., Bryden, L., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0419 · Cited by 569
Assessment of cumulative evidence on genetic associations: interim guidelines
Ioannidis, J. P., Boffetta, P., Little, J., O'Brien, T. R., Uitterlinden, A. G., Vineis, P., Balding, D. J., Chokkalingam, A., Dolan, S. M., Flanders, W. D., et al. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dym159 · Cited by 552 · cited 2×
“Furthermore, this association is one of the few showing ‘strong’ epidemiologic credibility when applying interim grading criteria of the Human Genome Epidemiology Network (16).”
Research works printed but not linked: 3
- 2007, 54, 713
- 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 150, 50
- 2004, 43, 605
Cited by
Items 201–287 of 287
Frecuencias genotípicas y alélicas de apolipoproteina e (APOE) en una muestra de adultos en Bogotá
Gómez, C. R., Gutiérrez-Castañeda, L. D., Pedraza, O. L., Torres-Tobar, L. A., Acevedo, G. H., Suárez, A., Lozano-Ruiz, A. G., & Camacho, I. (2021) · Revista Repertorio de Medicina y Cirugía · doi:10.31260/repertmedcir.01217372.1008 · Cited by 3
Editorial: Multi-omics, Epigenomics, and Computational Analysis of Neurodegenerative Disorders
Jaiswal, M. K. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.930425 · Cited by 3
“Similarly, in FTD (Ferrari et al., 2014), AD (Bertram and Tanzi, 2009), PD (Kia et al., 2021), Aging (Walter et al., 2011), and Dementia (Moreno-Grau et al., 2019) GWAS has led to the identification of few candidate genes, novel loci and unique associations, with evidence of disease-associated…”
BackgroundToward a Systematic Understanding of Epigenetic Contribution to Normal Aging and Alzheimer’s Disease
Zhang, Z., Cui, X., & Zhang, W. (2025) · RNA technologies · doi:10.1007/978-3-031-91072-2_16 · Cited by 2
Biphasic Role of Microglia in Healthy and Diseased Brain
Kumar, M., Arora, P., & Sandhir, R. (2022) · Springer eBooks · doi:10.1007/978-981-16-8313-8_18 · Cited by 3
Overlooked Alzheimer’s Smoking Gun?
Říčný, J. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1086-0 · Cited by 2
“shown to be risk factors for AD pathogenesis [3].”
Banerjee, A. K., & Arora, N. (2018) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000439 · Cited by 2
“[73], Tosto and Reitz [74] and recently by”
BackgroundCharacterizing G-quadruplex mediated regulation of amyloid precursor protein expression
Crenshaw, E. M. D., Saunders, A. J., & Akins, M. R. (2016) · iDEA - Drexel University Institutional Repository · doi:10.17918/etd-7245 · Cited by 2
Tang, A., Zeng, B., Rankin, K. P., Miller, B. L., Gorno‐Tempini, M. L., Seeley, W. W., Rosen, H. J., Rabinovici, G. D., Oskotsky, T., Sirota, M., et al. (2025) · medRxiv · doi:10.1101/2025.10.01.25336815 · Cited by 2
Contribution bioinformatique à l' analyse du transcriptome humain
Loe-Mie, Y. (2012) · theses.fr (ABES) · doi:10.70675/f7344a01z716fz4daazac73z9f74619e270b · Cited by 2
“spécifiques des cellules étudiées mais, depuis l'établissement du premier protocole d'isolation d'ARN [42], le principe n'a pas changé.”
BackgroundFatty acid intake and cognitive decline
Plourde, M. (2011) · Elsevier eBooks · doi:10.1533/9780857092922.3.525 · Cited by 1
Galvin, J. E. (2012) · Wiley eBooks · doi:10.1002/9781119952930.ch73 · Cited by 1
Online-Datenbanken und systematische Metaanalysen komplex-genetischer Erkrankungen
Lill, C. M., & Bertram, L. (2010) · Medizinische Genetik · doi:10.1007/s11825-010-0225-0 · Cited by 1
Self-citationKanyemba, A. (2016) · University of Zimbabwe Institutional Repository (University of Zimbabwe) · Cited by 1
A Systems Perspective of Complex Diseases: From Reductionism to Integration
Bandesh, K., Dhar, P. K., & Bharadwaj, D. (2018) · RNA technologies · doi:10.1007/978-3-319-92967-5_2 · Cited by 1
Generating Cell Type-Specific Protein Signatures from Non-symptomatic and Diseased Tissues
Sadick, J. S., Crawford, L. A., Cramer, H. C., Franck, C., Liddelow, S. A., & Darling, E. M. (2020) · Annals of Biomedical Engineering · doi:10.1007/s10439-020-02507-y · Cited by 1
Morgan, L. M. (2012) · Duke University Press eBooks · doi:10.1215/9780822395478-004 · Cited by 1
Pharmacogenomics and Personalized Medicine in Alzheimer’s Disease
Archer, T., & Johansson, B. E. A. (2013) · Springer eBooks · doi:10.1007/978-81-322-1184-6_15 · Cited by 1
Innovative perspectives on the value of diagnostic tests in clinical practice
Estrada-Orozco, K., & Cuervo-Rojas, J. (2024) · Colombian Journal of Anesthesiology · doi:10.5554/22562087.e1108 · Cited by 1
Beaton, D., Rieck, J. R., Alhazmi, F. H., ADNI, & Abdi, H. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/235945 · Cited by 1
“[80] and hippocampal atrophy in AD [40].”
The Effects of Neurosteroids, such as Pregnenolone Sulfate and its receptor, TrpM3 in the Retina.
Webster, C. M. (2019) · eScholarship (California Digital Library) · Cited by 1
Brabec, J. L., Lara, M. K., Tyler, A. L., & Mahoney, J. M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.03.539189 · Cited by 1
Ananth, M. R., Gardus, J. D., Huang, C., Palekar, N., Slifstein, M., Záborszky, L., Parsey, R. V., Talmage, D. A., DeLorenzo, C., & Role, L. W. (2024) · Research Square · doi:10.21203/rs.3.rs-3851086/v1 · Cited by 1
A Haplotype-Based Permutation Approach in Gene-Based Testing
Brand, H. (2013) · D-Scholarship@Pitt (University of Pittsburgh)
Methods in and applications of the sequencing of short non-coding RNAs
Ryvkin, P. (2013) · ScholarlyCommons (University of Pennsylvania)
Pin1: A New Enzyme Pivotal for Protecting Against Alzheimer’s Disease
Nakamura, K., Ma, S. L., & Lu, K. P. (2011) · InTech eBooks · doi:10.5772/20852
“In addition, recent genome-wide association approaches have delivered several additional AD susceptibility loci that are common in the general population (reviewed in Bertram & Tanzi, 2009).”
Simmons, C. R. (2011) · UKnowledge (University of Kentucky)
Dorman, H., Meschino, W. S., Allanson, J. E., Blaine, S., Cremin, C., Gibbons, C., Honeywell, C. R., Permaul, J., & Carroll, J. C. (2009) · PubMed Central
Molecular Epidemiology of Breast Cancer
Harlid, S. (2011) · Lund University Publications (Lund University)
GAB2 (GRB2-associated binding protein 2)
Brummer, T. (2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/44870
De genetica van de ziekte van Alzheimer
de Bruijn, R., & Ikram, M. A. (2012) · Neuropraxis · doi:10.1007/s12474-012-0002-8
The Genomics of Type 1 Diabetes Susceptibility Regions and Effect of Regulatory SNPs
Beka, S. E. (2016) · University of Hertfordshire Research Archive (University of Hertfordshire) · doi:10.18745/th.17200
Investigating changes in human brain phospholipids during normal ageing
Hancock, S. E. (2015) · Research Online (University of Wollongong)
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Brummer, T. (2010)
Pharmacogenomics in Developing Countries
Spector, S. A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-411464-7.00020-1
Investigating the Frequency of DNA Words near Loci Associated with Human Complex Traits
Chadha, K. (2018) · TSpace (University of Toronto)
Gaulton, K. J. (2010) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/7kgv-va68
Genetic Analysis of Complex and Mendelian Diseases
Griffin, N. M. (2014) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/3yga-tw23
Sartori, M. (2018) · theses.fr (ABES) · doi:10.70675/505633b5zb239z45edza4a7zab6e6c7b36ac
Brookhouser, N. (2020) · UA Campus Repository (The University of Arizona)
Bioinformatic approaches for integration of genomic information
Paananen, J. (2012) · UEF eRepo (University of Eastern Finland)
Pearman, W. S. (2019) · Massey Research Online (Massey University)
(2017) · Questions de personne · doi:10.3917/dbu.vande.2017.01.0467
VEGF and its role in the treatment of Diabetes and Alzhiemer’s Disease
Gangyan, M., & Kumar, P. (2021) · International Conference on Image Information Processing (ICIIP) · doi:10.1109/iciip53038.2021.9702619
(2012) · Duke University Press eBooks · doi:10.1215/9780822395478-015
Current awareness in geriatric psychiatry
(2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2393
Obulesu, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816412-9.00006-9
Hales, C., & Levey, A. I. (2011) · Oxford University Press eBooks · doi:10.1093/obo/9780199828340-0004
(2012) · Duke University Press eBooks · doi:10.1215/9780822395478-014
Alzheimer's disease and the amyloid hypothesis: A critical review
Kepp, K. P. (2022) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.7711806
Bertoline, L. M. F. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2023.tde-30052023-164253
Carruthers, M. N. (2023) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.23994753
The Genetics of Alzheimer’s Disease and the role of non-long coding RNAs in disease pathogenesis
Roy, S., Biswas, S., Guha, D., Dasgupta, R., & Bagchi, A. (2024) · doi:10.52756/bhstiid.2024.e01.001
Role of tanycytes in Tau clearance and their relevance in Alzheimer's disease
Sauvé, F. (2022) · theses.fr (ABES) · doi:10.70675/25300be3z6219z4081z98a4z9dbe9641b2d2
Family History of Common Adult‐Onset Disorder
FRCP, E. S. T. B. M. P., Michael Connor MD, D., & Malcolm Ferguson-Smith MBChB. RCPath, F. (2011) · Wiley eBooks · doi:10.1002/9781394322091.ch14
Development of Biomaterials for Neural Tissue Engineering
Walczak, P. A. (2024) · Aston Publications Explorer (Aston University) · doi:10.48780/publications.aston.ac.uk.00047380
Chronic two-photon imaging of neuronal activity in alzheimer's disease animal models
Bhat, A. (2012) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-72425
Bayesian Variable Selection Methods for Genome-Wide Association Studies with Categorical Phenotypes
Rowe, B. (2020) · Digital Scholarship - UNLV (University of Nevada Reno) · doi:10.34917/23469751
Sullivan, M. A., Lane, S. D., McKenzie, A. D. J., Ball, S. R., Sunde, M., Neely, G. G., Moreno, C. L., Maximova, A., Werry, E. L., & Kassiou, M. (2024) · Figshare · doi:10.6084/m9.figshare.24946342
Wehle, S., Decker, M. W., & Sotriffer, C. (2016) · Online Publication Service of Würzburg University (Würzburg University)
Alcolea, D. A., Blesa, R., & de Medicina, U. A. D. B. D. (2015) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Granados, E. A. O. (2014) · Repositorio Institucional UN - Biblioteca Digital
The Impact of INPP5D on Microglia Response to Tau Pathology in Alzheimer's Disease
Soni, D. (2025) · IUScholarWorks (Indiana University) · doi:10.7912/ga1a-ga83
The Role of INPP5D in Microglial Function and Amyloid Pathogenesis
Lin, P. B. (2023) · IUScholarWorks (Indiana University) · doi:10.7912/yxj0-rn10
Aktív és domesztikált piggyBac transzpozázok funkcionális vizsgálata
Wachtl, G. (2023) · Eötvös Loránd Tudományegyetem · doi:10.15476/elte.2022.284
Etude de l'expression de recombinases néogéniques dans le cancer colorectal
Arnaoty, A. (2013) · theses.fr (ABES) · doi:10.70675/ae2c888dz8452z40efz92a9z667ad8e674b4
Étude de la toxicité du peptide amyloïde beta Aß42 dans la levure Saccharomyces cerevisiae
Vignaud, H. (2013) · theses.fr (ABES) · doi:10.70675/6302176az9bd5z4c38zbe9fzd5ea83654ddc
Translational potential of the touchscreen-based methodology to assess cognitive abilities in mice
Delotterie, D. F. (2014) · theses.fr (ABES) · doi:10.70675/3cdfec89zb109z45e3za5efz6cf4227ad610
Physiological and pathological roles of the amyloid precursor protein at the presynapse
Jordá-Siquier, T. (2021) · theses.fr (ABES) · doi:10.70675/3bff9a77z3935z4d28zb02bz5b454bcbc77e
Lee, J. K. (2026) · WakeSpace Scholarship (Wake Forest University)
jeevangi, S., & Elemmi, M. C. (2026) · Research Square · doi:10.21203/rs.3.rs-9154535/v1
Navigating New Frontiers in Lipase Regulation
Jean-Baptiste, U. (2026) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/ej1m-qe48
Microglial APOE Across Alzheimer’s Disease-Relevant Pathologies
Nolt, G. L. (2026) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2026.311
Targett, I. L. (2026) · UWE Research Repository (UWE Bristol)
Landon, B., Daniel, A. A., Fischer, T., Phillips, N., Barber, R. C., Reynolds, A. W., & The Health and Aging Brain Study: Health Disparities (HABS-HD) Study Team (2026) · medRxiv · doi:10.64898/2026.10.05.26364777
Zhao, P., Lai, S., Dai, S., Zhou, C., Li, N., & Yu, W. (2026) · Biomedicines · doi:10.3390/biomedicines14102342
Diabetes Mellitus: Review of the Common, Rare, and Uncommon (Conceptual and Metaphorical) Types
Pliszka, M., & Szablewski, L. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27219611
Wang, K.-W., Yuan, Y.-X., Zhu, B., Zhang, Y., Wei, Y.-F., Meng, F.-S., Zhang, S., Wang, J.-X., & Zhou, J.-Y. (2023) · doi:10.3389/fnagi.2023.1277731.s001
Genetische Polymorphismen und Progressionsgeschwindigkeit der Alzheimer-Demenz
Wolff, M. (2013) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4096
A selected review of recent biological psychiatric research in China (translated version).
Fu, Y., Hu, S., & LAM, L. C. W. (2010) · PubMed
Human Stem Cell Approaches to Understanding and Treating Alzheimer’s Disease
Goldstein, L. S. B. (2013) · Research and perspectives in neurosciences · doi:10.1007/978-3-642-36648-2_7
Metadata
- Authors
- Bertram, L., & Tanzi, R. E.
- Affiliations
- Max Planck Institute for Molecular Genetics (DE)
- Massachusetts General Hospital (US)
- Corresponding author
- Bertram, L.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-10-06
- Volume
- 18
- Issue
- R2
- Pages
- R137-R145
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- PMC
- PMC2758713
- OpenAlex
- W2164868723
- Cited by
- 257
- References
- 40
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 15 · 2023: 14 · 2022: 13 · 2021: 13 · 2020: 13 · 2019: 6 · 2018: 16 · 2017: 10 · 2016: 12 · 2015: 9 · 2014: 11 · 2013: 16 · 2012: 32
- FWCI
- 3.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- Alzheimer's disease, genome-wide association study, genetic susceptibility loci, apolipoprotein E, Gab2, Galp, TNK1, clusterin, pathogenesis
- MeSH terms
- Alzheimer Disease, Humans, Genome, Human, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.